Solanezumab Does Not Slow Cognitive Decline in Preclinical Alzheimer Disease

WEDNESDAY, July 19, 2023 -- For patients with preclinical Alzheimer disease, solanezumab does not slow cognitive decline, according to a study published online July 17 in the New England Journal of Medicine to coincide with the annual Alzheimer's...